1.ION-EXCHANGER COLORIMETRY FOR MEASURING IRON (Ⅱ) IN POWDERED MILK FORTIFIED WITH IRON (Ⅱ)
Sen YANG ; Guoqin WEI ;
Acta Nutrimenta Sinica 1956;0(01):-
A new spectrophotometric method, ion-exchanger colorimetry for measuring iron (Ⅱ) in powdered milk fortified with iron(Ⅱ) has been developed. The method was based on the direct measurement of the resin phase absorbance after the absorption of colored sample complex species. In this method, 1,10-phenanthroline was used as the colour reagent, citric acid-sodium citrate as buffer and citric acid-ammonia as masking agent.The recovery rate of the method was 102%. Coefficient of variation was 5.84%.This method was a sensitive, reliable and simple analytical method for the determination of iron (Ⅱ) in powdered milk fortified with iron (Ⅱ).It was also possible to determine iron(Ⅱ) in powder milk and other food.
2.Analysis of cell parameter in peripheral blood of occupational n-hexane exposed workers.
Feng ZHU ; Wei-sen ZHANG ; Hui ZUO
Chinese Journal of Industrial Hygiene and Occupational Diseases 2007;25(7):402-403
Adult
;
Female
;
Hematologic Tests
;
Hexanes
;
adverse effects
;
Humans
;
Male
;
Occupational Exposure
;
adverse effects
;
Young Adult
4.The design and application of HIS-based inpatient expense check system
Guiping HU ; Mingju WANG ; Sen WEI
China Medical Equipment 2015;(6):43-45
Objective: To prevent the error of overcharging fees, missing fees and mistaken identity fees, check the inpatient expense rationality with using the self-developed software system. Methods:With extracting data from HIS and other systems, check and audit the inpatient expense, such as billing classification, red account records, logic checks, integrity checks, etc, according to pre-established rules. Results:Using the auditing software can greatly improve the work efficiency and the accuracy of inpatient expense, reduce the incidence of billing dispute issue. Conclusion:This system has valuable reference and be worth generalizing because it can bring the social benefit to hospital.
6.Research progress of β-arrestins in fibrotic diseases
Yuanjing GU ; Wuyi SUN ; Sen ZHANG ; Jingjing WU ; Wei WEI
Chinese Pharmacological Bulletin 2015;(2):170-174,175
β-arrestins, a kind of important adaptor protein and signal transduction protein found in the purification process ofβ-adrenergic receptor kinase (β-ARK) ,were first identified as pro-teins that have the ability to desensitize G protein-coupled recep-tors ( GPCR) . Fibrosis is defined by the overgrowth, hardening, and scarring of various tissues and is attributed to excess deposi-tion of extracellular matrix ( ECM ) components including colla-gen . A large number of studies have shown thatβ-arrestins play an important role in the process of fibrotic diseases, involved in inflammatory response and excess deposition of ECM. This re-view discusses the research status and development prospects ofβ-arrestins-mediated fibrotic diseases.
10.Clinical features and prognostic factors of alveolar soft part sarcoma in 15 patients
Xin SUN ; Wei GUO ; Rongli YANG ; Shun TANG ; Sen DONG
China Oncology 2009;19(10):784-787
Background and purpose: Alveolar soft part sarcoma (ASPS) is a rare malignant neoplasm characterized by slow growth and indolent behavior, and most of the patients had metastases in diagnoses. This study was to define clinical features and assess prognostic factors of ASTS. Methods: Between January 2003 and December 2008, there were 15 patients with ASTS who received treatment and were followed up in the Department of Orthopedic Ontology of Peking University People's Hospital. We retrospectively analyzed the clinical factors of the disease related to prognosis: gender, age, tumor size, primary tumor site, metastatic sites, local recurrence, the roles of postoperative radiotherapy and postoperative chemotherapy. Resnlts: At a follow-up from 7 to 76 months, only 2 patients had local recurrences after excision, but there was a high incidence of pulmonary metastases. Only 6 patients achieved disease free survival, 5 patients died of metastases or other complications. The five-year overall survival rates was 41.7%, and the median survival time was 42.0 months. Univariate analysis and Cox regression analysis revealed that tumor size, tumor primary site and metastases at diagnoses were prognostic factors, but not gender and age, Conclusion: Alveolar soft part sarcoma is a high grade malignant soft tissue neoplasm with frequent metastases to lung, bone or brain. Tumor size, primary tumor site and metastases at diagnoses are some of the prognostic factors. Chemotherapy or radiotherapy after surgery have no benefit to the survival in our analysis. Further prospective studies are needed to clarify the best strategy for the treatment of ASPS.